TissGeneSummary for CYP46A1 |
Gene summary |
Basic gene information | Gene symbol | CYP46A1 |
Gene name | cytochrome P450, family 46, subfamily A, polypeptide 1 | |
Synonyms | CP46|CYP46 | |
Cytomap | UCSC genome browser: 14q32.1 | |
Type of gene | protein-coding | |
RefGenes | NM_006668.1, | |
Description | CH24Hcholesterol 24-hydroxylasecytochrome P450 46A1cytochrome P450, subfamily 46 (cholesterol 24-hydroxylase) | |
Modification date | 20141207 | |
dbXrefs | MIM : 604087 | |
HGNC : HGNC | ||
Ensembl : ENSG00000036530 | ||
HPRD : 04970 | ||
Vega : OTTHUMG00000171510 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_CYP46A1 | |
BioGPS: 10858 | ||
Pathway | NCI Pathway Interaction Database: CYP46A1 | |
KEGG: CYP46A1 | ||
REACTOME: CYP46A1 | ||
Pathway Commons: CYP46A1 | ||
Context | iHOP: CYP46A1 | |
ligand binding site mutation search in PubMed: CYP46A1 | ||
UCL Cancer Institute: CYP46A1 | ||
Assigned class in TissGDB* | C | |
Included tissue-specific gene expression resources | HPA,TiGER | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | Brain | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | GBM,LGG | |
Reference showing the relevant tissue of CYP46A1 | ||
Description by TissGene annotations | Have significant anti-correlated miRNA |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID | GO:0006707 | cholesterol catabolic process | 18621681 | GO:0006805 | xenobiotic metabolic process | 20667828 | GO:0006707 | cholesterol catabolic process | 18621681 | GO:0006805 | xenobiotic metabolic process | 20667828 |
Top |
TissGeneExp for CYP46A1 |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
BRCA | -1.468427696 | 0.250175813 | -1.718603509 | 3.16E-35 | 5.99E-34 |
THCA | -0.853879286 | 0.199147832 | -1.053027119 | 5.19E-09 | 2.69E-08 |
KIRP | -0.74399025 | 0.36700975 | -1.111 | 5.71E-06 | 2.49E-05 |
BLCA | -2.667094362 | -0.980999625 | -1.686094737 | 0.000551 | 0.004423913 |
KICH | 0.686288375 | -0.351295625 | 1.037584 | 3.68E-05 | 0.000104385 |
Top |
TissGene-miRNA for CYP46A1 |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
UCS | hsa-miR-296-5p | MIMAT0000690 | 0.027 | -0.31 | 56 |
Top |
TissGeneMut for CYP46A1 |
TissGeneSNV for CYP46A1 |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.R252C | SKCM | 1 |
p.G184D | HNSC | 1 |
p.D37G | SARC | 1 |
p.S246I | COAD | 1 |
p.E116K | SKCM | 1 |
p.D1A | UCEC | 1 |
p.Q175E | ESCA | 1 |
p.V172M | LUAD | 1 |
p.A8S | HNSC | 1 |
p.S436T | STAD | 1 |
p.E269K | SKCM | 1 |
p.R260H | ESCA | 1 |
p.G56D | BLCA | 1 |
p.E166K | BRCA | 1 |
p.R107H | ESCA | 1 |
p.P408L | UCEC | 1 |
p.V172M | STAD | 1 |
p.L150* | HNSC | 1 |
p.R400Q | LIHC | 1 |
p.V87I | PAAD | 1 |
p.R147W | LGG | 1 |
p.R415C | SKCM | 1 |
p.L361M | UCEC | 1 |
p.G72R | SKCM | 1 |
p.T225A | SKCM | 1 |
p.R219H | HNSC | 1 |
p.R98L | LUAD | 1 |
p.S149F | SKCM | 1 |
p.G117A | STAD | 1 |
p.S106F | SKCM | 1 |
p.W50* | LUSC | 1 |
p.V325M | STAD | 1 |
p.D142E | COAD | 1 |
p.E132D | LUAD | 1 |
p.W134C | LUAD | 1 |
p.R251L | LUAD | 1 |
p.V300L | SARC | 1 |
p.E137Q | BLCA | 1 |
p.L143P | KIRC | 1 |
p.G68E | SKCM | 1 |
p.E89K | SKCM | 1 |
p.E54* | HNSC | 1 |
p.W50R | BLCA | 1 |
p.R467H | COAD | 1 |
p.R58H | LUSC | 1 |
p.G221E | SKCM | 1 |
p.R110S | KIRP | 1 |
p.G337D | HNSC | 1 |
p.R260C | ESCA | 1 |
p.R372H | HNSC | 1 |
p.D289N | READ | 1 |
p.R138Q | GBM | 1 |
p.R252H | BLCA | 1 |
p.V144I | HNSC | 1 |
p.R248C | SKCM | 1 |
p.R400W | STAD | 1 |
p.R76W | UCEC | 1 |
p.R244W | UCEC | 1 |
p.G417S | UCEC | 1 |
p.A14V | UCEC | 1 |
p.R244Q | HNSC | 1 |
p.R415H | UCEC | 1 |
p.T378A | SKCM | 1 |
p.G270D | BLCA | 1 |
p.P390L | SKCM | 1 |
p.R237Q | LIHC | 1 |
p.E92K | SKCM | 1 |
p.M398I | ESCA | 1 |
p.R95C | SKCM | 1 |
p.E137K | SKCM | 1 |
p.R244W | STAD | 1 |
p.N412K | KIRC | 1 |
p.N249K | KIRC | 1 |
p.R435H | BLCA | 1 |
p.R91Q | HNSC | 1 |
p.S436P | LIHC | 1 |
p.M183I | UCEC | 1 |
p.R272H | BLCA | 1 |
p.Y188* | BLCA | 1 |
p.K104N | READ | 1 |
p.E290K | SKCM | 1 |
p.R76W | CHOL | 1 |
p.D53N | SKCM | 1 |
p.R45Q | UCEC | 1 |
p.V55I | UCEC | 1 |
p.S431C | CESC | 1 |
p.K107N | KIRC | 1 |
p.D190G | UCEC | 1 |
p.G132E | SKCM | 1 |
Top |
TissGeneCNV for CYP46A1 |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for CYP46A1 |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Chimerdb3.0 | ChiTaRs | NA | AK095062 | ZNF708-CYP46A1 | chr19:21477544 | chr14:100192913 | |
TCGAfusionPortal | PRADA | BRCA | TCGA-AO-A0JD-01A | TRIP11-CYP46A1 | Out-of-frame | Chr14:92465584 | Chr14:100165803 |
Top |
TissGeneNet for CYP46A1 |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for CYP46A1 |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for CYP46A1 |
TissGeneDrug for CYP46A1 |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for CYP46A1 |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |
umls:C0002395 | Alzheimer's Disease | 22 | BeFree,CTD_human,GAD,LHGDN |
umls:C0338656 | Impaired cognition | 4 | BeFree |
umls:C0339573 | Glaucoma, Primary Open Angle | 3 | BeFree |
umls:C1270972 | Mild cognitive disorder | 3 | BeFree |
umls:C0242383 | Age related macular degeneration | 2 | BeFree,GAD |
umls:C0333463 | Senile Plaques | 2 | BeFree |
umls:C2936349 | Plaque, Amyloid | 2 | BeFree |
umls:C0085648 | Synovial Cyst | 1 | BeFree |
umls:C1258666 | Myxoid cyst | 1 | BeFree |
umls:C1314691 | Age at menarche | 1 | GAD |